ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

This study is currently recruiting participants.
Study NCT00717691.   Last updated on July 16, 2008.   Information provided by Dynasplint Systems, Inc.

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
Official Title  Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial
Brief Summary

The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.

Detailed Description

Determine the efficacy of dynamic splinting in treating patients with hallux limitus, in a randomized, controlled trial.

Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Single Group Assignment
Primary Outcome Measure  Change in Active Range of Motion of Hallux (great toe) Extension [ Time Frame: Two Months ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Change in passive Range of Motion, Extension [ Time Frame: same ] [ Designated as safety issue: No ]
Condition  Hallux Limitus
Intervention  Device: Metatarsophalangeal Extension Dynasplint System
Other: Standard of Care
MEDLINE PMIDs 17144945,   10416546,   17296132,   15778469,   12015407,   16467621,   12095117,   17972321,   11475452
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  50
Start Date  July 2008
Completion Date December 2008
Eligibility Criteria 

Inclusion Criteria:

  • Reduced flexibility in AROM of extension in the great toe
  • Pain that is worsened by walking and/or squatting
  • Impaired gait pattern

Exclusion Criteria:

  • Metatarsal stress fracture
  • Interdigital neuroma
  • Sesamoid pathology
  • Gout
  • Metatarsalgia
Gender Both
Ages 18 Years to 90 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Stanley R Kalish, DPM, FACFAS     770-477-9535     srkalish@bellsouth.net    
Contact: Buck Willis, PhD     866-720-1914     BWillis@dynasplint.com    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00717691
Organization ID 2008.003
Secondary IDs ††
Study Sponsor  Dynasplint Systems, Inc.
Collaborators ††
Investigators 
Principal Investigator:     Stanley R Kalish, DPM, FACFAS     Atlanta Foot and Leg Clinic    
Information Provided By Dynasplint Systems, Inc.
Verification Date July 2008
First Received Date  July 15, 2008
Last Updated Date July 16, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers